Psyomics

About:

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

Website: http://www.psyomics.com

Top Investors: Martlet Capital, Parkwalk Advisors, EASME - EU Executive Agency for SMEs, University of Cambridge Enterprise, Hertfordshire Partnership University NHS Foundation Trust

Description:

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.